Exploring IMDC Treatment Strategies at ESMO 2024 with Professor Manuela Schmidinger – MediaMedic

MediaMedic posted on LinkedIn:

“Exploring IMDC Treatment Strategies at ESMO 2023.

Oncology Frontier interviewed Professor Manuela Schmidinger at ESMO 2024 to discuss IMDC management for variable risk patients. Current studies show significant benefits of combined immunotherapy, especially for intermediate or poor-risk patients. Professor Schmidinger shared her insights on these treatment strategies and the latest advancements.

Stay tuned for the full interview!”

View the video attached to the post.
Source: MediaMedic/LinkedIn